Charles City, IA, United States of America

Brian T Becicka

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cambrex Charles City, Inc.. Active years: 2011.



Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian T Becicka: Innovator in Pharmaceutical Processes

Introduction

Brian T Becicka is a notable inventor based in Charles City, Iowa. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of anhydrous aripiprazole. His innovative approach has led to advancements in the efficiency and quality of pharmaceutical compounds.

Latest Patents

Brian T Becicka holds a patent for a process titled "Process for preparing anhydrous Aripiprazole type I." This patent describes a method for preparing Type I anhydrous aripiprazole by dissolving aripiprazole (or an acid salt thereof) in an alcoholic solvent, which may contain water, at elevated temperatures. The process involves adding seed crystals of Type 1 anhydrous aripiprazole to the solution, cooling the mixture, and isolating the crystals. The final step includes drying the isolated crystals to obtain low moisture Type 1 anhydrous aripiprazole. This innovative method enhances the quality of the pharmaceutical product.

Career Highlights

Brian T Becicka is currently associated with Cambrex Charles City, Inc., where he applies his expertise in pharmaceutical processes. His work at Cambrex has allowed him to focus on developing efficient methods for drug preparation, contributing to the company's reputation in the pharmaceutical industry.

Collaborations

Due to space constraints, the collaborations section has been omitted.

Conclusion

Brian T Becicka's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to advancing drug preparation processes. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…